Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HELLO-study: Levetiracetam in Brain Tumor Epilepsy
NCT00571155Phase 4Completed
- Sponsor
- University Hospital Tübingen
- Start
- Dec 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by University Hospital Tübingen. Primary endpoint: Feasibility of standardized treatment at 1 year. Started Dec 2007; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00571155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571155.